Why did ORPH.IR stock spike in pre-market volume today?

ORPH.IR stock spiked to **15,112** shares pre-market due to concentrated order flow versus the **192** average. Small-float liquidity and speculative interest in clinical-trial news often cause such spikes; confirm with post-open volume and company announcements.

What are the key valuation metrics for ORPH.IR stock?

Key metrics for ORPH.IR stock: **PE 7.75**, **PB 1.85**, current ratio **1.89**, ROE **26.97%**, and operating margin near **20.50%**. These imply modest valuation but sensitivity to contract timing.

What price targets does Meyka AI give for ORPH.IR stock?

Meyka AI's forecast model projects a 3-month target of **EUR 0.20** (+42.86%) and a 12-month target of **EUR 0.32** (+128.57%) versus the current **EUR 0.14**. Forecasts are projections and not guarantees.

How should traders manage risk on ORPH.IR stock after the volume spike?

Traders should wait for confirmed post-open volume, use intraday VWAP and set stops near **EUR 0.12**, and size positions small given the stock’s low absolute price and large percentage swings following a **78.71x** relative volume event.

EU Stocks

Volume 15,112 for ORPH.IR Open Orphan EURONEXT pre-market 13 Jan 2026: watch levels

ByDanny Kontos January 13, 2026January 13, 2026

A sharp pre-market volume spike pushed ORPH.IR stock activity to 15,112 shares on 13 Jan 2026, versus a 50-day average of 0.14 (price) and 192 average daily volume. The jump lifts relative volume to 78.71x, signalling short-term trader interest in Open Orphan Plc on EURONEXT. We view the move as a liquidity event that connects directly to valuation and technical levels. This note summarises what drove the spike, how company fundamentals stack up, and how traders and investors can interpret Meyka AI model forecasts and risk metrics before the open.